Comparison Chart Agenus Inc.

Stocks

AGEN

US00847G8042

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-08-28 EDT			5-day change	1st Jan Change
7.660 ^USD	-1.92%		-5.32%	+143.95%

08-28	Agenus Reports Peer-Reviewed Publication of Mature Phase 1B Results for Botensilimab Plus Balstilimab in Microsatellite-Stable Metastatic Colorectal Cancer	CI
08-26	Agenus Reports Updated Nest Phase 2 Results for Neoadjuvant Botensilimab and Balstilimab in Resectable Colon Cancer	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	AGENUS INC.	Other Biotechnology & Medical Research	-1.92%	-5.32%	+143.95%	+83.25%	-93.88%	345M